This Phase 1 study is the first clinical trial in Japanese subjects. This study is designed to evaluate the single- and multiple-dose pharmacokinetics, safety and tolerability of PF-04171327 oral tablet in healthy adult Japanese and Western subjects in fasting and fed conditions.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01362673?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
